
Business as unusual: 4 things to do to better in your philanthropic journey
The four things successful families do to navigate the uncertainties of the modern world. ...

by Alfredo De Massis Published March 20, 2026 in Family business • 7 min read
Most innovators stand on the shoulders of giants, but in a race to innovate, invent, and ideate, family businesses are dismissing old knowledge – wisdom that could hold the key to their next breakthrough.
In a family enterprise, tradition is valued and respected yet simultaneously seen as something to overcome. New generations often enter with a hunger to shift products, modernize processes, and diversify portfolios alike. It’s what I have often coined the tradition and innovation paradox, where old values intersect with new ideas.Â
However, new research demonstrates that the two worlds do not stand in opposition; they can and should be recombined and reinterpreted to create new market offerings. Innovation is no longer about invention, but reinvention and reinterpretation, and in this article, I translate these research findings into actionable insights you can use to transform institutional memories into new market offerings.
Most organizations sit on vast pools of historical and archival data, writing them off as outdated or irrelevant. Century-old ideas, technologies, perspectives, and institutional memories are often left stuck in time. But ironically, this isn’t what history has taught us to do.
Some of the world’s most seminal products were developed by recombining established knowledge components. For example, 3M’s flexible circuit is based on technologies that date almost a century but was commercialized only a few decades ago to develop electronic devices, such as LCD screens, laptop keyboards, robots, and biomedicine. Other notable examples include Polaroid’s combination of its legacy instant photography technology with digital imaging and social media, as well as the invention of television based on the recombination of seven different technologies that existed for decades. Research has long recognized that a firm is shaped but not necessarily trapped by its past.
This is precisely what we refer to as recombinant innovation, the process in which atypical or unexpected combinations of knowledge generate novel outcomes. However, like much existing research in the family business field, while many studies have theorized why recombinant innovation  works, very few have explored how organizations can achieve it. Even fewer have been able to translate those learnings into practitioner insights.
Drawing on findings from research that I recently co-authored with Vittoria Magrelli, Josip Kotlar, Federico Frattini, and Antonio Messeni Petruzzelli, and featuring the case studies of Italian healthcare firm Aboca and Turkey-based industrial and financial conglomerate Sabanci Holding, I help you recover, revive, and renew existing family knowledge to remain competitive.

Aboca is an Italian healthcare company that combines centuries-old herbal remedies with evidence-based medicine to develop breakthrough products. Founded in 1978 by Valentino Mercati and Rosetta del Bene in Tuscany, Italy – an area renowned for the cultivation and use of medicinal plants. Aboca is now a European leader in the production and distribution of medical devices and dietary supplements, all based on natural substances extracted from medicinal plants. The company’s revenue surpassed €311m during our research, which also saw 37 national and international patents and 75 product lines developed and launched in a relatively short period of time.
However, the firm’s competitiveness does not lie solely within scientific research. Like many enterprising families, the Mercatis boast a family museum which includes the Aboca Bibliotheca Antiqua, a dedicated library housing 3,000 printed volumes from the 15th to the 20th century on the therapeutic value of plants, more than 38,000 digitized and stored old medicinal recipes, and around 12,000 digitized botanical sheets. Aboca uses this old knowledge alongside modern scientific research to compete in the healthcare industry, and it works. The company is known in over 25 countries for its highly innovative and distinctive therapeutic natural products.
The firm’s capacity to thrive in a highly competitive industry is deeply rooted in its ability to create new opportunities for innovation and shape a new market ecosystem by relying on old knowledge.
Aboca bridged the gap between past and present, crafting a distinctive market position that appealed to both
tradition-conscious and science-oriented consumers.
Aboca bridged the gap between past and present, crafting a distinctive market position that appealed to both tradition-conscious and science-oriented consumers. Its success is rooted in a multi-level process that can be reinterpreted in family businesses across every sector. It involves three key recombinant innovation phases: recovering, reviving, and renewing:
First, leaders need to systematically focus on recovering, restoring, and digitizing historical materials such as books, recipes, and artifacts, transitioning them from external, exogenous resources to organized and accessible knowledge bases.
In the case of Aboca, teams then reinterpreted this knowledge and used it to challenge existing assumptions. It enabled the family firm to transcend the conventional supplements market, giving rise to a new segment of therapeutic solutions derived from natural substances and validated by modern science.
In the second phase of the recombinant process, organizations are introduced to the newly reinterpreted knowledge, and it is used to steer new discussions around market and product offerings. Crucially, this phase also involves overcoming deeply embedded cultural and value systems within the organization to sustain its innovative approach.
For Aboca, this organizational reframing enabled the company to develop therapeutic natural products, such as treatments targeting respiratory inflammation rather than merely suppressing coughs.
From individual to company to industry, this third and final phase is about introducing new products and services, shaped by old knowledge, to market.
For Aboca, this is where innovations were validated and repositioned in emerging market spaces, ensuring they aligned with regulatory standards and consumer expectations. Strategic actors play a pivotal role at this stage at Aboca in legitimizing and repositioning herbal formulations to align with broader market and innovation goals.
This phase emphasizes how an organization projects its innovations outward, broadening the level of analysis to address external market dynamics and industry positioning.
The family created new combinations of old knowledge and used it to inspire business decisions internally and externally through its entrepreneurial channel.
This isn’t just applicable to healthcare either. Turkey-based Sabanci Holding recently featured on the Family Business Centre’s philanthropy webinar series. While the focus of the conversation was the family’s structured approach to giving, it was the current generations’ reinterpretation of family values and use of digital technology to bring old knowledge to life that made it so remarkable.
Nowgen’s Melisa Sabanci Tapan told IMD how she used artificial intelligence (LLMs) to translate the family’s physical and digital archives into a digital version of her great-grandfather – a bot that allowed her to apply his wisdom and vision to modern situations in a consistent and aligned way. What began as an internal engagement and decision-making tool later evolved into a new business discipline – a podcast series, through which Sabanci Tapan shares his old knowledge with new generations beyond the family. The family created new combinations of old knowledge and used it to inspire business decisions internally and externally through its entrepreneurial channel.
Recombinant innovation not only generates novel products but can also create entirely new product categories. The key lesson is that the past can be a rich source of innovation if treated as a dynamic resource rather than a nostalgic reference. Firms in industries such as food, wellness, fashion, or cosmetics, where tradition adds value, can gain a competitive edge by combining old knowledge with modern science, crafting a unique innovation narrative that resonates with both regulators and consumers. For businesses looking to follow in the footsteps of Aboca and the Sabanci family, they must follow this three-phase framework, which in short means:

Professor of Entrepreneurship and Family Business
Alfredo De Massis is ranked as the most influential and productive author in the family business research field in the last decade in a recent bibliometric study. De Massis is an IMD Professor of Entrepreneurship and Family Business at IMD where he holds the Wild Group Chair on Family Business and works with other universities worldwide.

March 9, 2026 • by Peter Vogel, Etienne Eichenberger in Family business
The four things successful families do to navigate the uncertainties of the modern world. ...

February 3, 2026 • by Peter Vogel, Toshio Goto in Family business
Drawing on lessons from family businesses, Toshio Goto and Peter Vogel explore the drivers of family enterprise longevity. Rather than prescribing longevity as a universal goal, they highlight the strengths of the...

January 6, 2026 • by Peter Vogel in Family business
Melisa Sabancı Tapan, in conversation with IMD’s Peter Vogel, discusses creating empowered communities, bringing the wisdom of the past to new generations through AI, and staying human in a digital world.  ...

December 11, 2025 • by Peter Vogel in Family business
A family-first view of the transformations reshaping global family wealth, drawing insights from the IMD-FBN Family Office Report. ...
Explore first person business intelligence from top minds curated for a global executive audience